University of Tokyo researchers have elucidated how Toll-like receptor 9 (TLR9) binds to pathogen DNA, activating the innate immune system. This discovery is vital for the design of new antiviral, antibacterial, allergy and other drugs targeting TLR9.
from The Medical News http://ift.tt/1CPpCVD
from The Medical News http://ift.tt/1CPpCVD
No comments:
Post a Comment